Kidoguchi et al. [44] showed the natriuretic effect of Azilsartan by inhibiting the WNK4-SPAK-NCC pathway through sympathetic inhibitory activity in a model of adenine-induced chronic renal failure. The gene discussed is STK39; the disease is chronic kidney disease.